HP
SONM icon

Harvey Partners’s DNA X Inc SONM Stock Holding History

Harvey Partners’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-849
Closed -$1.25M – 39
2021
Q1 		$1.25M Sell
849
-26
-3% -$45.9K 0.87% 35
2020
Q4 		$1.14M Buy
875
+250
+40% +$273K 0.79% 35
2020
Q3 		$873K Buy
625
+208
+50% +$334K 1.13% 35
2020
Q2 		$607K Buy
+417
New +$666K 0.73% 32

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Harvey Partners's SONM Position: Q2 2021 in Review

Harvey Partners sold out of DNA X Inc (SONM) in Q2 2021, closing a stake of 849 shares — an estimated $1.25M sold.

Harvey Partners first reported a position in SONM in Q2 2020 and held it in 4 quarters. The position peaked at $1.25M in Q1 2021. 17 funds tracked by Wall St. Rank hold SONM as of Q2 2021.

  • Harvey Partners reported no remaining DNA X Inc position as of Q2 2021 after selling out during the quarter.
  • Harvey Partners sold 849 DNA X Inc shares in Q2 2021, an estimated $1.25M.
  • Harvey Partners first reported a position in DNA X Inc in Q2 2020 and held it in 4 quarters.
  • Harvey Partners's DNA X Inc position peaked at $1.25M in Q1 2021.
  • 17 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2021.

Based on Harvey Partners's 13F filing for Q2 2021, filed 16 Aug 2021.